NCT07488845

Brief Summary

  • To determine the incidence and types of vascular injuries associated with pediatric supracondylar humerus fractures.
  • Identify outcomes of different management strategies
  • Identify risk factors for vascular injury

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Apr 2026May 2027

First Submitted

Initial submission to the registry

March 7, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 23, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 7, 2026

Last Update Submit

March 19, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence of vascular complications in patients with supracondylar humerus fractures

    baseline

Secondary Outcomes (1)

  • Predictors of vascular complications in pediatric supracondylar humerus fractures.

    baseline

Study Arms (3)

Patients with intact pulse will be followed up for 48 hours after fixation

NO INTERVENTION

Pink pulseless hand

OTHER

): Patients with no pulse, but with good biphasic distal doppler signals, well perfused hand capillary refill time less than 3 seconds, and normal oxygen saturation. Patients in this group will be managed by watchful observation for 48 hours after fixation. Vascular exploration will only be indicated if hand ischemia, loss of distal doppler signals, or deterioration of digital oxygen saturation occur

Procedure: vascular exploration

Pale pulseless hand

ACTIVE COMPARATOR

Patients with no pulse or distal doppler signals, and delayed capillary refill time will undergo immediate vascular exploration and injuries will be documented and managed accordingly.

Procedure: vascular exploration

Interventions

Patients with no pulse or distal doppler signals, and delayed capillary refill time will undergo immediate vascular exploration and injuries will be documented and managed accordingly.

Pale pulseless handPink pulseless hand

Eligibility Criteria

AgeUp to 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ● Children Diagnosed with supracondylar humerus fracture (Gartland I-IV) aged under 15 years.
  • Presented within 1st 48 hrs of injury.

You may not qualify if:

  • ● Old trauma \>48 hours
  • Previous vascular intervention in the same limb
  • Another fracture in the same limb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Egypt

Location

Related Publications (14)

  • Dabis J, Daly K, Gelfer Y (2016): Supracondylar fractures of the humerus in children: a review of management and controversies. Orthopedic & Muscular System, 5(01): 1-4.

    BACKGROUND
  • Benedetti Valentini M, Farsetti P, Martinelli O et al. (2013): The value of ultrasonic diagnosis in the management of vascular complications of supracondylar fractures of the humerus in children. The Bone & Joint Journal, 95(5): 694-698.

    BACKGROUND
  • Schoenecker P, Delgado E, Rotman M et al. (1996): Pulseless arm in association with totally displaced supracondylar fracture. Journal of Orthopaedic Trauma, 10(6): 410-415

    BACKGROUND
  • Farnsworth C, Silva P, Mubarak S (1998): Etiology of supracondylar humerus fractures. Journal of Pediatric Orthopaedics, 18(1): 38-42.

    BACKGROUND
  • . Barr L (2014): Pediatric supracondylar humeral fractures: Epidemiology, mechanisms, and incidence during school holidays. Journal of Children's Orthopedics, 8:167-170

    BACKGROUND
  • Cheng J, Lam T, Maffulli N (2001): Epidemiological features of supracondylar fractures of the humerus in Chinese children. Journal of Pediatric Orthopedics, 10(1): 63-67.

    BACKGROUND
  • Leiblein, M., Weber, C., Marzi, I., Barker, J.H. and Nau, C., 2017. Neurovascular complications after supracondylar humerus fractures in children. Trauma Case Reports, 8, pp.16-19. https://doi.org/10.1016/j.tcr.2017.02.001.

    BACKGROUND
  • . Hosam Roshdy M, Khaled El Alfy M, Hesham Sharaf M et al. (2016): Vascular Complications of Supracondylar Humeral Fractures in Pediatrics. Egyptian Journal of Vascular and Endovascular Surgery, 12: 1-5

    BACKGROUND
  • Usman R, Jamil M, Hashmi J (2017): Management of arterial injury in children with supracondylar fracture of the humerus and a pulseless hand. Annals of Vascular Diseases, 10(4): 402-406.

    BACKGROUND
  • Shaw B, Kasser J, Emans J et al. (1990): Management of vascular injuries in displaced supracondylar humerus fractures without arteriography. Journal of Orthopaedic Trauma, 4(1): 25-29

    BACKGROUND
  • . Garg S, Weller A, Larson A et al. (2014): Clinical characteristics of severe supracondylar humerus fractures in children. Journal of Pediatric Orthopaedics, 34(1): 34- 39.

    BACKGROUND
  • Lebowitz C, Matzon J (2018): Arterial injury in the upper extremity: evaluation, strategies, and anticoagulation management. Hand Clinics, 34(1): 85-95.

    BACKGROUND
  • Mohammadzadeh M, Mohammadzadeh M, Mohammadzadeh A et al. (2012): Arterial damage accompanying supracondylar fractures of the humerus. Trauma Monthly, 16(4): 160-165

    BACKGROUND
  • Wu J, Perron A, Miller M et al. (2002): Orthopedic pitfalls in the ED: pediatric supracondylar humerus fractures. The American Journal of Emergency Medicine, 20(6): 544-550.

    BACKGROUND

Central Study Contacts

Mina Mamdouh Fakher

CONTACT

Hesham Elsayed Aboloyon

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 7, 2026

First Posted

March 23, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

March 23, 2026

Record last verified: 2026-03

Locations